Oral Board Review Course (2026): Saturday
Availability
Registration Required
(0 seats available)
Expires on Jan 24, 2029
Online Meeting
Jan 24, 2026 7:00 AM - 7:00 PM ET
Cost
LIST: $1,865.00
Member - Active: $1,495.00
Member - Resident: $1,495.00
Member - APP: $1,495.00
NonMember - Resident: $1,865.00
NonMember - APP: $1,495.00
Credit Offered
6 AMA PRA Category 1 Credit Credits
6 Participation Credits

Saturday Session: SOLD OUT

Sunday Session: SOLD OUT

This is for the Saturday Program:

The 2026 AUA Oral Board Review Course will take place as a live virtual course.

The purpose of the AUA Oral Board Review Course is to prepare attendees for the American Board of Urology (ABU) Certifying Examination (Part II). The course will provide attendees with practical preparation skills for taking the urology oral board exam and valuable realistic practice with the exam format. This is a highly interactive course that simulates the oral board exam given by the American Board of Urology. Attendees participate in two 75-minute mock oral exams, an Objective Structured Clinical Examination (OSCE) session in a small group learning format, an interactive case analysis with expert examiners and an “Ask the Experts” panel discussions with Faculty who offer tips & tricks for preparing for and successfully completing the oral examination.

In addition to experiencing mock oral exams that are designed to reproduce the format and feel of the American Board of Urology exam, attendees will also receive immediate, individualize, and detailed feedback and guidance from expert oral examiners.  They will also have the opportunity to refine their thought process, communication skills, decision-making ability, and approach to oral exam and OSCE question types.


Attendees must choose the Saturday OR Sunday Program when registering but not both. 

Please select which program day you wish to be in at the time of registration.  The selection is a first come basis and will be completed once you register. 

Note: All course registrants will receive their final and detailed schedules via a Tips Before You Click email scheduled to arrive on or before January 16, 2026.

AUA Guarantee: This course is backed by the AUA Guarantee: If you fail the boards, then we will pay for you to retake our course until course capacity is reached. (Applicable 2025 registrants please call 1-800-908-9414) 


AUA Members save 25%! For more information on membership benefits, visit www.AUAnet.org/Join

Registration Fees

Do not miss out on this valuable preparation with additional supporting sessions for your upcoming boards!

All for one low price—Register Now Before the Course is Sold Out!

 

Virtual Live Course 

Early Bird

On or Before December 11, 2025

Virtual Course Late

On or after

December 12, 2025

Oral Board Study Guide App*

AUA Member $1495 $1865 $160
AUA Non-Member $1865 $2330

*Discounted Pricing on the Oral Board Study Guide App For Course Registrants Only (Regularly $315) 

Urologist

At the conclusion of this activity, the learner will:

  1. Navigate the oral board exam format, components and question types successfully
  2. Utilize interpersonal and communication skills resulting in effective information exchange.
  3. Demonstrate and refine skills to effectively manage exam anxiety.
  4. Develop greater self-awareness and confidence in the oral examination setting. 
  5. Apply the practical experienced gained from mock oral exams and individualized feedback to better prepare for the American Board of Urology oral board exam.
  6. Practice and become familiar with the Objective Structured Clinical Examinations (OSCEs). 

FACULTY DISCLOSURES

Faculty disclosures will be posted here prior to the start of the course. 

Education Council Disclosures:

PDF icon Education Council DTL 2025.pdf

COI Review Work Group Disclosures:

PDF icon COI Review Workgroup DTL 2025.pdf

AUA Office of Education Staff has nothing to disclose

All relevant financial relationships have been mitigated.

AUA ACCREDITATION INFORMATION

ACCREDITATION: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: The American Urological Association designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: All persons in a position to control the content of a CME activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible company (formerly commercial interests) during the previous 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The AUA must determine if the individual’s relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of relevant financial relationships that result in conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.